564 related articles for article (PubMed ID: 11895935)
1. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine.
Kang HY; Srinivasan J; Curtiss R
Infect Immun; 2002 Apr; 70(4):1739-49. PubMed ID: 11895935
[TBL] [Abstract][Full Text] [Related]
2. PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.
Xin W; Li Y; Mo H; Roland KL; Curtiss R
Infect Immun; 2009 Oct; 77(10):4518-28. PubMed ID: 19687204
[TBL] [Abstract][Full Text] [Related]
3. Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization.
Kang HY; Curtiss R
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):99-104. PubMed ID: 12832112
[TBL] [Abstract][Full Text] [Related]
4. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae.
Nayak AR; Tinge SA; Tart RC; McDaniel LS; Briles DE; Curtiss R
Infect Immun; 1998 Aug; 66(8):3744-51. PubMed ID: 9673257
[TBL] [Abstract][Full Text] [Related]
5. Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis.
Xin W; Wanda SY; Li Y; Wang S; Mo H; Curtiss R
Infect Immun; 2008 Jul; 76(7):3241-54. PubMed ID: 18458067
[TBL] [Abstract][Full Text] [Related]
6. Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen.
Kong Q; Liu Q; Roland KL; Curtiss R
Infect Immun; 2009 Dec; 77(12):5572-82. PubMed ID: 19805538
[TBL] [Abstract][Full Text] [Related]
7. The Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccine.
Xin W; Wanda SY; Zhang X; Santander J; Scarpellini G; Ellis K; Alamuri P; Curtiss R
Infect Immun; 2012 Oct; 80(10):3621-33. PubMed ID: 22868499
[TBL] [Abstract][Full Text] [Related]
8. A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.
Frey SE; Lottenbach KR; Hill H; Blevins TP; Yu Y; Zhang Y; Brenneman KE; Kelly-Aehle SM; McDonald C; Jansen A; Curtiss R
Vaccine; 2013 Oct; 31(42):4874-80. PubMed ID: 23916987
[TBL] [Abstract][Full Text] [Related]
9. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
Chen H; Schifferli DM
Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
[TBL] [Abstract][Full Text] [Related]
10. A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.
Li Y; Wang S; Xin W; Scarpellini G; Shi Z; Gunn B; Roland KL; Curtiss R
Infect Immun; 2008 Nov; 76(11):5238-46. PubMed ID: 18765737
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated
Łaniewski P; Baek CH; Roland KL; Curtiss R
mBio; 2017 Aug; 8(4):. PubMed ID: 28830946
[No Abstract] [Full Text] [Related]
12. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA.
Li Y; Wang S; Scarpellini G; Gunn B; Xin W; Wanda SY; Roland KL; Curtiss R
Proc Natl Acad Sci U S A; 2009 Jan; 106(2):593-8. PubMed ID: 19114649
[TBL] [Abstract][Full Text] [Related]
13. Recombinant BCG expressing a PspA-PdT fusion protein protects mice against pneumococcal lethal challenge in a prime-boost strategy.
Goulart C; Rodriguez D; Kanno AI; Lu YJ; Malley R; Leite LC
Vaccine; 2017 Mar; 35(13):1683-1691. PubMed ID: 28242071
[TBL] [Abstract][Full Text] [Related]
14. Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae.
Muralinath M; Kuehn MJ; Roland KL; Curtiss R
Infect Immun; 2011 Feb; 79(2):887-94. PubMed ID: 21115718
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of regulated delayed attenuation strategies for Salmonella enterica serovar Typhi vaccine vectors in neonatal and infant mice.
Shi H; Wang S; Curtiss R
Clin Vaccine Immunol; 2013 Jun; 20(6):931-44. PubMed ID: 23616408
[TBL] [Abstract][Full Text] [Related]
16. Effect of deletion of gene cluster involved in synthesis of Enterobacterial common antigen on virulence and immunogenicity of live attenuated Salmonella vaccine when delivering heterologous Streptococcus pneumoniae antigen PspA.
Liu Q; Shen X; Bian X; Kong Q
BMC Microbiol; 2020 Jun; 20(1):150. PubMed ID: 32513100
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers.
Shi H; Wang S; Roland KL; Gunn BM; Curtiss R
Clin Vaccine Immunol; 2010 Mar; 17(3):363-71. PubMed ID: 20053873
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses.
Miyaji EN; Dias WO; Tanizaki MM; Leite LC
FEMS Immunol Med Microbiol; 2003 Jun; 37(1):53-7. PubMed ID: 12770760
[TBL] [Abstract][Full Text] [Related]
19. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae.
Vadesilho CF; Ferreira DM; Moreno AT; Chavez-Olortegui C; Machado de Avila RA; Oliveira ML; Ho PL; Miyaji EN
Microb Pathog; 2012; 53(5-6):243-9. PubMed ID: 22981893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
